Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Trevi Therapeutics, Inc.
AI Executive Summary
AI-powered analysis of 8-K filing content
Trevi Therapeutics stockholders approved amendments to the 2019 Stock Incentive Plan on June 3, 2026, increasing available shares by 8 million and implementing stricter compensation controls to align pay with performance and reduce shareholder dilution.
Key Takeaways
8,000,000 additional shares authorized for issuance under the amended 2019 Stock Incentive Plan
Non-employee director compensation has been limited to control costs and align with governance best practices
1 more takeaway